These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Essential experience in surgical treatment of esophageal cancer in China over the past five decades]. Huang GJ Zhonghua Zhong Liu Za Zhi; 2007 Oct; 29(10):795-7. PubMed ID: 18396698 [No Abstract] [Full Text] [Related]
23. [Gastric cancer--a comprehensive review on epidemiological and clinical data and results of treatments in Japan]. Takasu S; Yamazaki T Nihon Rinsho; 1993 Jan; 51 Suppl():713-26. PubMed ID: 8459607 [No Abstract] [Full Text] [Related]
24. Prognostic factors for the survival of patients with esophageal carcinoma in the U.S.: the importance of tumor length and lymph node status. Eloubeidi MA; Desmond R; Arguedas MR; Reed CE; Wilcox CM Cancer; 2002 Oct; 95(7):1434-43. PubMed ID: 12237911 [TBL] [Abstract][Full Text] [Related]
25. [Controversies on the treatment of early esophageal cancer]. Endo M; Yoshida M; Murata Y; Kumegawa A; Okushima N Gan No Rinsho; 1984 May; 30(6 Suppl):634-8. PubMed ID: 6748236 [TBL] [Abstract][Full Text] [Related]
26. The number of metastatic lymph nodes and the ratio between metastatic and examined lymph nodes are independent prognostic factors in esophageal cancer regardless of neoadjuvant chemoradiation or lymphadenectomy extent. Mariette C; Piessen G; Briez N; Triboulet JP Ann Surg; 2008 Feb; 247(2):365-71. PubMed ID: 18216546 [TBL] [Abstract][Full Text] [Related]
27. [The dynamics of esophageal cancer morbidity in Kazakhstan]. Pozdniakova AP; Kolycheva NI; Adil'gireeva SKh; Abdrakhimov BE Vopr Onkol; 1992; 38(9):1055-61. PubMed ID: 1300818 [No Abstract] [Full Text] [Related]
29. Potential for lead-time and length-time biases in outcomes in esophageal adenocarcinoma. Rubenstein JH; Inadomi JM Am J Gastroenterol; 2009 Dec; 104(12):3106-7; author reply 3107-8. PubMed ID: 19956133 [No Abstract] [Full Text] [Related]
30. Malignant melanoma of the digestive system. Mills SE; Cooper PH Pathol Annu; 1983; 18 Pt 2():1-26. PubMed ID: 6674858 [No Abstract] [Full Text] [Related]
31. Influence of neoadjuvant chemoradiation on the number and size of analyzed lymph nodes in esophageal cancer. Bollschweiler E; Besch S; Drebber U; Schröder W; Mönig SP; Vallböhmer D; Baldus SE; Metzger R; Hölscher AH Ann Surg Oncol; 2010 Dec; 17(12):3187-94. PubMed ID: 20585867 [TBL] [Abstract][Full Text] [Related]
32. Small cell carcinoma of the esophagus. Analysis of 14 cases and literature review. Hosokawa A; Shimada Y; Matsumura Y; Yamada Y; Muro K; Hamaguchi T; Igaki H; Tachimori Y; Kato H; Shirao K Hepatogastroenterology; 2005; 52(66):1738-41. PubMed ID: 16334769 [TBL] [Abstract][Full Text] [Related]
33. Improved outcomes in the management of esophageal cancer with the addition of surgical resection to chemoradiation therapy. McKenzie S; Mailey B; Artinyan A; Metchikian M; Shibata S; Kernstine K; Kim J Ann Surg Oncol; 2011 Feb; 18(2):551-8. PubMed ID: 20839062 [TBL] [Abstract][Full Text] [Related]
34. [Achalasia and carcinoma of the esophagus: incidence, prevalence and prognosis]. Brücher BL; Stein HJ; Feussner H; Bartels H; Siewert JR Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():1357-9. PubMed ID: 9931881 [TBL] [Abstract][Full Text] [Related]
35. Total number of resected lymph nodes predicts survival in esophageal cancer. Altorki NK; Zhou XK; Stiles B; Port JL; Paul S; Lee PC; Mazumdar M Ann Surg; 2008 Aug; 248(2):221-6. PubMed ID: 18650631 [TBL] [Abstract][Full Text] [Related]
36. Risk stratification for early esophageal adenocarcinoma: analysis of lymphatic spread and prognostic factors. Barbour AP; Jones M; Brown I; Gotley DC; Martin I; Thomas J; Clouston A; Smithers BM Ann Surg Oncol; 2010 Sep; 17(9):2494-502. PubMed ID: 20349213 [TBL] [Abstract][Full Text] [Related]
37. Significant host- and tumor-related factors for predicting prognosis in patients with esophageal carcinoma. Ikeda M; Natsugoe S; Ueno S; Baba M; Aikou T Ann Surg; 2003 Aug; 238(2):197-202. PubMed ID: 12894012 [TBL] [Abstract][Full Text] [Related]
38. Claim for screening endoscopy of the esophagus. Lenglinger J; Riegler M Am J Gastroenterol; 2009 Oct; 104(10):2632-3; author reply 2633. PubMed ID: 19806097 [No Abstract] [Full Text] [Related]
39. [Multivariate prognostic analysis for patients with unresectable esophageal carcinoma after concurrent chemoradiotherapy]. Chen EC; Liu MZ; Hu YH; Li QQ; Liu H; Cai L; Liu H; Lin HX; Huang Y; Wang HY; Cui NJ Ai Zheng; 2005 Jun; 24(6):731-4. PubMed ID: 15946490 [TBL] [Abstract][Full Text] [Related]
40. Prognostic role of PGE2 receptor EP2 in esophageal squamous cell carcinoma. Kuo KT; Wang HW; Chou TY; Hsu WH; Hsu HS; Lin CH; Wang LS Ann Surg Oncol; 2009 Feb; 16(2):352-60. PubMed ID: 19050969 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]